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Abstract Cyclic GMP phosphodiesterase (PDE) is rod photo-
receptor disk membrane-associated via C-terminal lipid tails.
PDEN, a recently identified subunit, was shown to disrupt PDE/
membrane interaction under physiological conditions, without
affecting PDE catalytic activity. We found that a PDEN
ortholog from the eyeless nematode Caenorhabditis elegans
(termed CEN) solubilizes bovine PDE in vitro with an EC50 very
similar to PDEN. Immobilized PDEN and CEN both bind, in
addition to bovine PDE, an N-terminal fragment of human
retinitis pigmentosa GTPase regulator, but not rhodopsin kinase
and Ran binding protein 1. The results suggest that PDEN and
CEN may regulate membrane binding of a variety of proteins in
photoreceptors and other tissues.
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Key words: Phototransduction; Membrane attachment;
cGMP phosphodiesterase; Mammalian retina;
Caenorhabditis elegans C27H5.1 gene product
1. Introduction
Rod photoreceptor phosphodiesterase (PDE) holoenzyme
consists of three subunits termed PDEK, PDEL and PDEQ
[1^3]. PDEK and PDEL contain the catalytic sites of the en-
zyme, PDEQ acts as an inhibitor [4]. PDEK and PDEL are
anchored to the rod disk membrane via farnesyl- and gera-
nylgeranyl side chains, respectively, which are attached to the
C-terminal cysteine residue [5^7]. A putative fourth subunit,
termed PDEN, co-purifying with bovine PDE, was identi¢ed
[8] and subsequently cloned and expressed [9]. The recombi-
nant protein was shown to solubilize PDE very similarly to
the native protein [9]. Proteolytic removal of the C-terminal
region of PDE catalytic subunits resulted in loss of interaction
between PDEN and PDE suggesting involvement of the lipid
side chains. The PDEN gene, located on human chromosome
2q35^36, expresses a single mRNA species [10,11]. Multiple
tissue Northern blots suggested that PDEN is expressed in
tissues other than retina [9,12], while rod PDE is considered
retina-speci¢c. Results from a yeast two-hybrid screening sug-
gested that human PDEN interacts with RPGR [12], a GTPase
regulator involved in X-linked retinitis pigmentosa [13], and
the small GTP binding protein, rab13 [14], both of which are
ubiquitously expressed.
A gene with similar exon/intron arrangement was identi¢ed
in the eyeless nematode Caenorhabditis elegans [15] as part of
the genome sequencing project, with the systematic identi¢ca-
tion tag C27H5.1. The gene product, in the following termed
CEN, was shown to be very similar in sequence to PDEN, and
in part, at the C-terminal domain, to the retina-speci¢c pro-
tein HRG4 [16]. Both CEN and HRG4 have no known func-
tion. HRG4 is a homolog of the C. elegans gene unc-119 that
is expressed in C. elegans neurons [17]. To investigate whether
hPDEN, CEN, and HRG4 share similar functions, we cloned
and expressed these polypeptides in bacteria and analyzed
their ability to solubilize PDE, and to interact with other
retinal proteins.
2. Materials and methods
2.1. Cloning of CEN and HRG4
The cloning of human PDEN was described previously [10]. The
coding region of CEN was ampli¢ed from a mixed stage C. elegans
cDNA library (from Dr. Susan Mango, University of Utah) with N-
terminal sense primer 5P-CAC ATA TGG CCA CTA CGC TAC
TCG and C-terminal antisense primer 5P-TAT TAG TCG TAA
TAA AGA CGG AC. Human RG4 cDNA was ampli¢ed from a
human retinal cDNA library (obtained from Dr. Jeremy Nathans,
Johns Hopkins University) using an N-terminal sense primer 5P-
GCA TAT GAA GGT GAA GAA GAA GG and Vgt10 reverse
primer. NdeI sites (underlined) were introduced at N-termini to facil-
itate subsequent cloning into expression vectors. The PCR products
were cloned into PCR2.1 vector (Invitrogen) and sequenced from both
strands with the tagged primers using a Licor L40000 automatic se-
quencer [18].
2.2. Site-directed mutagenesis of human PDEN
QuickChange site-directed mutagenesis kit (Stratagene) was used to
create C-terminal truncations of hPDEN. The primers for truncating
the last 10 amino acid of PDEN are 5P-GAC GAC GAT CTT TGA
GTA AGC ACA TCC (sense) and 5P-GGA TGT GCT TAC TCA
AAG ATC GTC GTC (antisense); the primers for truncating the last
20 amino acids are 5P-GGG AAC GTT ATC TGA GAA ACA AAG
TTT (sense) and 5P-AAA CTT TGT TTC TCA GAT AAC GTT
CCC (antisense). In-frame stop codons are underlined. The resulting
mutants (M1 and M2) were sequenced on both strands.
2.3. Bacterial expression vectors and puri¢cation of hPDEN-thioredoxin
and glutathione S-transferase (GST) fusion proteins
Human PDEN cDNA lacking the 5P untranslated region was am-
pli¢ed with N-terminal primer 5P-GCC ATA TGT CAG CCA AGG
ACG and T7 and cloned into PCR2.1 vector. The thioredoxin expres-
sion vector was constructed by cloning the EcoRI-PstI digested frag-
ment of human PDEN into ThioHisA vector. The plasmids thio-HN,
thio-M1 and thio-M2 were transformed into Top10 cells (Invitrogen).
The NdeI-EcoRI fragments of PCR products were cloned into NdeI-
EcoRI sites of pGEX-2TKcs [19]. The recombinant plasmids GK-
hPDEN, GK-M1, GK-M2, GK-CEN and GK-HRG4 were trans-
formed into BL21 (DE3) plysS strain (Novagen).
The thioredoxin fusion proteins (thio-hPDEN, thio-M1 and thio-
M2) were isolated by a procedure slightly modi¢ed from the manu-
facturer’s protocol (Invitrogen). Expressed proteins were denatured
with 8 M urea and dialyzed against lysis bu¡er before they were
puri¢ed on Probond columns. GST fusion proteins (GK-HN, GK-
CEN and GK-HRG4) were isolated as described previously [7]. Fusion
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protein was cleaved by treating with biotinylated human thrombin
(thrombin cleavage capture kit, Novagen) at room temperature for
2 h. The recombinant protein was dialyzed against 50% glycerol,
100 mM NaCl, 50 mM Tris, pH 8.0, 1 mM EDTA and stored at
320‡C.
2.4. Preparation of bovine (ROS) and extract of ROS proteins
Bovine ROS membranes were prepared from fresh bovine retinas
[20]. 0.5 ml ROS (bleached, 3 mg rhodopsin/ml) were washed twice in
2 ml hypotonic bu¡er (20 mM Tris, 0.1 mM DTT, 0.1 mM EDTA)
with 1% Triton X-100, 2 mM GTP and 1 mM PMSF. The homoge-
nate was centrifuged at 15 000 rpm for 30 min and the supernatant
containing solubilized proteins was collected.
2.5. Protein determinations, SDS-PAGE and immunoblotting
The concentrations of proteins [21], SDS-PAGE [22] and Western
blot were carried out as previously described [1,7].
2.6. PDE activity assay
Puri¢ed recombinant proteins were incubated with ROS membrane
diluted in ROS bu¡er and incubated for the time and temperature as
indicated. The samples were centrifuged at 15 000 rpm for 30 min at
4‡C to separate supernatants and the membranes [9]. PDE activity
was measured by recording release of protons with a pH microelec-
trode (MI-410, Microelectrodes, Inc.) in a bu¡er containing 20 mM
MOPS pH 8.0, 0.15 M KCl, 2 mM MgCl2. The ¢nal concentration of
cGMP was 2 mM [23].
2.7. In vitro transcription/translation
For construction of vectors expressing human RPGR and Ran
binding protein 1 (Ran BP1) in vitro, the N-terminus (residues 1^
372) of human RPGR (GenBank accession number Q92834) and
the coding region of human Ran BP1 (GenBank accession number
D38076) were ampli¢ed and cloned into NdeI and XbaI sites of the
pAGA vector [24] (constructs T7-RPGRN and T7-BP1). For con-
struction of vectors expressing and mouse rod PDEK and PDEL,
the respective coding regions were cloned into pAGA (constructs
T7-PDEA and T7-PDEB, respectively). The constructs were linearized
and expressed under the control of T7 promoter in TNT coupled
reticulocyte lysate system (Promega) for 90 min at 30‡C, with incor-
poration of [35S]methionine. 5 Wl of the ¢nal translation mixture was
added to 20 Wl of SDS sample bu¡er, and 5 Wl was analyzed by SDS-
PAGE.
2.8. In vitro binding assay
The binding of retina proteins (or in vitro translated proteins) with
immobilized GK-hPDEN and GK-CEN was performed as described
[25]. 20 Wl GST fusion proteins immobilized on glutathione beads
were incubated at room temperature for 30 min, with 50 Wl of ROS
extract or 10 Wl of in vitro translation products in 500 Wl binding
bu¡er (20 mM Tris pH 7.5, 1 mM MgCl2, 0.1 mM EDTA, 100
mM NaCl, 1 mM DTT, 1 mM PMSF, 2.5 mg/ml BSA). Protein
complexes were washed three times with 1 ml binding bu¡ers and
twice with 1 ml binding bu¡er without BSA. The bound proteins
were released after adding 20 Wl 2USDS sample bu¡er. 5^10 Wl
were analyzed on SDS-PAGE.
3. Results and discussion
3.1. Recombinant hPDEN and CEN solubilize rod PDE from
ROS membrane
The PDEN amino acid sequence is nearly identically con-
served among species [10]. Bovine PDEN was previously ex-
pressed in insect cells and shown to be biologically active [9].
To facilitate the puri¢cation of the native and mutant pro-
teins, we expressed hPDEN, CEN, HRG4, M1 and M2 as GST
fusion proteins. The GST polypeptides GK-hPDEN, GK-CEN
and GK-HRG4 were mostly soluble, and after cleavage with
thrombin, the resulting K-hPDEN, K-CEN and K-HRG4 (K
denotes the kinase domain which is retained after cleavage
with thrombin) were used for activity assays. SDS-PAGE
analysis showed that the puri¢ed recombinant proteins are
homogeneous and exhibit the correct mobility (Fig. 1A). To
test for activity of the recombinant proteins, excess amounts
were incubated with puri¢ed ROS membrane in isotonic sol-
ution (Fig. 1B), conditions that favor membrane attachment
of PDE. The membrane portion and soluble portion of PDE
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Fig. 1. Expression of GST fusion proteins of hPDEN, CEN, and HRG4. A: The fusion proteins were cleaved with thrombin, retaining the kin-
ase domain (K). Lane 1, puri¢ed K-hPDEN. Lane 2, K-CEN. Lane 3, K-HRG4. Lane 4, 10 kDa protein ladder (Gibco BRL). B: Activity of
the puri¢ed proteins. ROS membranes (¢nal concentration: 1.5 mg/ml) were incubated with puri¢ed recombinant protein at 30‡C for 60 min,
pelleted, and the supernatant and pellet fractions assayed for PDE activity after trypsin activation, as described in Section 2. The results are
the average of two assays. C: Dose-dependent solubilization of ROS-PDE activity by recombinant hPDEN and CEN. Puri¢ed K-hPDEN or K-
CEN were incubated with ROS membranes and PDE activities were measured with the pH assay.
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were separated by centrifugation and the amount of PDE
activity in either portion was determined. The results show
that K-hPDEN was as active as recombinant PDEN expressed
in insect cells. K-CEN was nearly as active and solubilized the
majority of PDE from ROS membrane while K-HRG4
showed little e¡ect. When assayed in a dose-dependent man-
ner (Fig. 1C), the EC50 of CEN was 25.9 nM, which is very
close to the EC50 of PDEN (14.9 nM) under the same condi-
tions. The results show that a protein that is expressed in an
eyeless nematode has nearly the same biological activity as a
protein expressed in mammalian photoreceptors. Absence of
membrane detachment activity in the recombinant HRG4
suggests a more distant relationship of this protein to CEN/
PDEN.
3.2. The C-terminus of PDEN is essential for folding and
activity of the protein
The C-termini of PDEN and CEN contain Ser-Arg-Val
(SRV) and/or Phe-Tyr-Val (FYV) motifs that are thought to
be involved in interacting with PDZ domain-containing pro-
teins. The C-terminus of PDEN is also essential for its correct
cellular location when it is expressed in tissue culture [12]. We
therefore generated truncation mutants lacking 10 (M1) and
20 (M2) amino acids at the C-terminus. Both GK-M1 and
GK-M2, however, are insoluble even after treatment with 8
M urea and dialysis. We therefore expressed hPDEN and its
truncation mutants as thioredoxin fusion protein (thio-hPDEN,
thio-M1, thio-M2) in Escherichia coli (Fig. 2). The thioredoxin
fusion products were soluble in bu¡ers after 8 M urea treat-
ment, and showed the correct mobility on SDS gels (Fig. 2A).
When assayed for PDE membrane detachment, thio-hPDEN
disrupted membrane association in part, but was not as
active as PDEN expressed as GST fusion protein (Fig. 2B).
The thio-M1 and thio-M2 mutants, in contrast, were com-
pletely inactive. These results suggest that the PDEN C-termi-
nus is important for the activity and correct folding of the
protein.
3.3. Interaction of immobilized GST-hPDEN and GST-CEN
with other proteins
PDEN was previously shown to bind PDE catalytic subunits
by a gel ¢ltration assay [9]. While rod PDE is considered
retina-speci¢c, PDEN is thought to be expressed also in non-
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Fig. 2. A: SDS-PAGE analysis (12.5%) of puri¢ed recombinant thio-
fusion proteins expressed in E. coli. Puri¢ed thio-hPDEN (lane 1),
thio-M1 (lane 2), and thio-M2 (lane 3). Lane 4 contains 10 kDa
protein ladder. B: Activity of thio-hPDEN, and truncation mutants.
Conditions are as in the legend to Fig. 1.
Fig. 3. In vitro interaction of PDEN or CEN with PDE, RPGR, and Ran BP1. A: A⁄nity chromatography and Western blot of hypotonic bo-
vine ROS extracts bound to GST beads (lane 2), GST-hPDEN (lane 3), and GST-CEN (lane 4). Lane 1, soluble bovine ROS proteins as a con-
trol. The antibody was anti-PDE polyclonal antibody (MOE). B: 35S-labeled in vitro translated mouse PDEK (lanes 1, 5 and 9), mouse PDEL
(lanes 2, 6 and 10), human RPGR-N (lanes 3, 7 and 11), and human Ran BP1 (lanes 4, 8 and 12) were incubated with GST alone (lanes 1^4),
GST-hPDEN (lanes 5^8), or GST-CEN (lanes 9^12). The binding of the proteins was anlyzed by SDS-PAGE and autoradiography. Lanes 13^16
are mPDEK, mPDEL, human RPGR-N, and human Ran BP1 translated in vitro.
N. Li, W. Baehr/FEBS Letters 440 (1998) 454^457456
retina tissues. To identify proteins distinct from PDE that
may interact with PDEN and CEN, we incubated GST-PDEN
and GST-CEN immobilized on glutathione beads with bovine
ROS components that were solubilized in hypotonic bu¡er.
Proteins binding to GST-hPDEN or GST-CEN were identi¢ed
by Western blotting. The result con¢rms the binding of hPDEN
to PDE, and show that CEN binds PDE indistinguishably
from hPDEN (Fig. 3A). When an identical blot was probed
with anti-rhodopsin kinase antibody, no binding between
PDEN and rhodopsin kinase was observed (results not shown).
To improve the sensitivity of the binding assay (speci¢c
antibodies to other proteins were unavailable), we exposed
the immobilized GST proteins to several peptide candidates
which were in vitro transcribed/translated using [35S]-
methionine as a tracer (Fig. 3B). The candidates were
RPGR, suggested to bind to PDEN [14], Ran BP1, a ubiqui-
tously expressed protein binding to Ran, a small GTPase in-
volved in nuclear import [26], and luciferase (negative con-
trol). As shown in Fig. 3B, both GST-PDEN and GST-CEN
bind individual PDE subunits PDEK, and PDEL. In addition,
a peptide comprising the N-terminal region of RPGR was
bound, while Ran BP1 and luciferase (not shown) were not
bound. GST alone did not interact with PDE, RPGR, or Ran
BP1. The interaction of PDEN with PDEKL or Rab13 implied
that the isoprenylated C-termini are necessary for its interac-
tion. However, the N-terminal RPGR peptide is not isopre-
nylated, and other isoprenylated retinal proteins, such as rho-
dopsin kinase, do not bind PDEN. The results suggest that
lipid modi¢cations are not essential for the binding.
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